
 |
| Fabrazyme A Treatment for Fabry Disease |
 |
 |
|
|
United States |
|
This web site is intended for use by European physicians only. You must log-in to use this site.
|
 |
|
|
|
| Related Site |
 |
 |
Fabry Community : Provides information and support for people with Fabry disease, their caregivers and families, and their health care providers.
Liver Amyloidosis : A gross specimen of a liver by Urbana Atlas of Pathology.
Cerebrotendinous Xanthomatosis : A description of this rare disease, its symptoms, diagnosis and treatment.
Wilson's Disease : A definition of this disease, clinical manifestations, diagnosis and treatment.
Facts on Hyponatremia : Article about over-hydration.
Menkes Disease : Medical information including pathophysiology, causes, clinical features, laboratory and histological findings. Also includes images.
Comprehensive Gaucher Treatment Center : Provides clinical evaluations for the diagnosis and treatment of patients with this disease. Information about the disease and the facility.
Gaucher Registry : Longitudinal, observational program that tracks the health outcomes of routine clinical practice for patients with Gaucher disease.
Fabry's Disease : About this disease its symptoms and possible complications, prognosis and treatment.
Heart - Amyloidosis : Picture of the heart affected by amyloidosis by the Urbana Atlas of Pathology.
|
|
|
 |
 |
 |
Health Tip: Screening for Cancer (HealthDay)
HealthDay - (HealthDay News) --
The best way to get a good prognosis when it comes to cancer is to get
diagnosed as early as possible -- and that's where cancer screening tests
come in. |
 |
Existing Drug May Lead to ALS Treatment (HealthDay)
HealthDay - TUESDAY, Oct. 20 (HealthDay News) -- A drug similar to one now used to
treat blood poisoning holds promise as a treatment for amyotrophic lateral
sclerosis, better known as ALS or Lou Gehrig's disease, researchers
say. |
 |
Berinert Approved for Rare Genetic Disease (HealthDay)
HealthDay - MONDAY, Oct. 12 (HealthDay News) -- Berinert (C1-esterase
inhibitor) has been approved by the U.S. Food and Drug Administration as
the first sanctioned treatment for a rare genetic disease called
hereditary angiodema (HAE), the agency said in a news release. |
|
|
 |